BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 11904338)

  • 21. Dendritic reticulum cell immunoreactivity for low-affinity nerve growth factor receptor in malignant lymphomas.
    Dorfman DM; Shahsafaei A
    Mod Pathol; 1996 Oct; 9(10):959-65. PubMed ID: 8902831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of the aldehyde dehydrogenase 2-like gene is controlled by BOB.1/OBF.1 in B lymphocytes.
    Brunner C; Laumen H; Nielsen PJ; Kraut N; Wirth T
    J Biol Chem; 2003 Nov; 278(46):45231-9. PubMed ID: 12947107
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inducible expression and phosphorylation of coactivator BOB.1/OBF.1 in T cells.
    Zwilling S; Dieckmann A; Pfisterer P; Angel P; Wirth T
    Science; 1997 Jul; 277(5323):221-5. PubMed ID: 9211847
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lymphoid-specific transcription mediated by the conserved octamer site: who is doing what?
    Matthias P
    Semin Immunol; 1998 Apr; 10(2):155-63. PubMed ID: 9618761
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of immunoglobulin transcription factors in primary intraocular lymphoma and primary central nervous system lymphoma.
    Coupland SE; Loddenkemper C; Smith JR; Braziel RM; Charlotte F; Anagnostopoulos I; Stein H
    Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):3957-64. PubMed ID: 16249468
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NF-κB-dependent signals control BOB.1/OBF.1 and Oct2 transcriptional activity in B cells.
    Kilzheimer M; Quandt J; Langhans J; Weihrich P; Wirth T; Brunner C
    Eur J Immunol; 2015 Dec; 45(12):3441-53. PubMed ID: 26361887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. T-bet, a T cell-associated transcription factor, is expressed in Hodgkin's lymphoma.
    Dorfman DM; Hwang ES; Shahsafaei A; Glimcher LH
    Hum Pathol; 2005 Jan; 36(1):10-5. PubMed ID: 15712176
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Downregulation of internal enhancer activity contributes to abnormally low immunoglobulin expression in the MedB-1 mediastinal B-cell lymphoma cell line.
    Ritz O; Leithäuser F; Hasel C; Brüderlein S; Ushmorov A; Möller P; Wirth T
    J Pathol; 2005 Feb; 205(3):336-48. PubMed ID: 15682441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The B-cell transcription factors BSAP, Oct-2, and BOB.1 and the pan-B-cell markers CD20, CD22, and CD79a are useful in the differential diagnosis of classic Hodgkin lymphoma.
    Browne P; Petrosyan K; Hernandez A; Chan JA
    Am J Clin Pathol; 2003 Nov; 120(5):767-77. PubMed ID: 14608905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of vascular endothelial growth factor in lymphomas and Castleman's disease.
    Foss HD; Araujo I; Demel G; Klotzbach H; Hummel M; Stein H
    J Pathol; 1997 Sep; 183(1):44-50. PubMed ID: 9370946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Catfish Oct2 binding affinity and functional preference for octamer motifs, and interaction with OBF-1.
    Ross DA; Lyles M; Ledford BE; Magor BG; Wilson MR; Miller NW; Clem LW; Middleton DA; Warr GW
    Dev Comp Immunol; 1999 Apr; 23(3):199-211. PubMed ID: 10402207
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BOB.1 of the channel catfish, Ictalurus punctatus: not a transcriptional coactivator?
    Richard ML; Hikima J; Wilson MR; Miller NW; Cunningham C; Warr GW
    Mol Immunol; 2009 Jan; 46(3):481-91. PubMed ID: 19041136
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD22 regulates early B cell development in BOB.1/OBF.1-deficient mice.
    Samardzic T; Gerlach J; Muller K; Marinkovic D; Hess J; Nitschke L; Wirth T
    Eur J Immunol; 2002 Sep; 32(9):2481-9. PubMed ID: 12207332
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of an expanded immunohistochemical panel to distinguish cutaneous Hodgkin lymphoma from histopathologic imitators.
    Cho RJ; McCalmont TH; Ai WZ; Fox LP; Treseler P; Pincus LB
    J Cutan Pathol; 2012 Jun; 39(6):651-8. PubMed ID: 22324490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Ets factor Spi-B is a direct critical target of the coactivator OBF-1.
    Bartholdy B; Du Roure C; Bordon A; Emslie D; Corcoran LM; Matthias P
    Proc Natl Acad Sci U S A; 2006 Aug; 103(31):11665-70. PubMed ID: 16861304
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transcriptional Coactivator BOB1 (OBF1, OCA-B) Modulates the Specificity of DNA Recognition by the POU-Domain Factors OCT1 and OCT2 in a Monomeric Configuration.
    Nazarov IB; Zilov DS; Gordeev MN; Potapenko EV; Yeremenko N; Tomilin AN
    Biomolecules; 2024 Jan; 14(1):. PubMed ID: 38254723
    [TBL] [Abstract][Full Text] [Related]  

  • 37. OBF1 and Oct factors control the germinal center transcriptional program.
    Song S; Cao C; Choukrallah MA; Tang F; Christofori G; Kohler H; Wu F; Fodor BD; Frederiksen M; Willis SN; Jackson JT; Nutt SL; Dirnhofer S; Stadler MB; Matthias P
    Blood; 2021 May; 137(21):2920-2934. PubMed ID: 33512466
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltratein Hodgkin's lymphoma.
    van den Berg A; Visser L; Poppema S
    Am J Pathol; 1999 Jun; 154(6):1685-91. PubMed ID: 10362793
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary gastric Hodgkin's lymphoma expressing a B-Cell profile including Oct-2 and Bob-1 proteins.
    Saito M; Tanaka S; Mori A; Toyoshima N; Irie T; Morioka M
    Int J Hematol; 2007 Jun; 85(5):421-5. PubMed ID: 17562619
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alterations of loci encoding PU.1, BOB1, and OCT2 transcription regulators do not correlate with their suppressed expression in Hodgkin lymphoma.
    Cavazzini F; De Wolf-Peeters C; Wlodarska I
    Cancer Genet Cytogenet; 2005 Apr; 158(2):167-71. PubMed ID: 15796964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.